Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 17INDUSTRY 6NIH 5OTHER_GOV 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

CNS 5Endocrine 1

Conditions

Neoplasms 79Lymphoma 62Breast Neoplasms 61Prostatic Neoplasms 60Multiple Myeloma 60Lung Neoplasms 55Neoplasm Metastasis 54Ovarian Neoplasms 47Leukemia, Myeloid, Acute 47Colorectal Neoplasms 41Hematologic Neoplasms 40Melanoma 39Carcinoma, Non-Small-Cell Lung 38Pancreatic Neoplasms 31Lymphoma, Non-Hodgkin 31Glioma 31Brain Neoplasms 30Urinary Bladder Neoplasms 28Myelodysplastic Syndromes 28Sarcoma 26Carcinoma, Renal Cell 26Glioblastoma 25Fallopian Tube Neoplasms 25Neuroblastoma 23Triple Negative Breast Neoplasms 22Leukemia, Lymphocytic, Chronic, B-Cell 22Burkitt Lymphoma 21Stomach Neoplasms 19Small Cell Lung Carcinoma 19Squamous Cell Carcinoma of Head and Neck 18

Interventions

Nivolumab 1Clinical Laboratory Techniques 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NIH × Spinal Cord Neoplasms × 1 year × Clear all
NCT00598351 2026-06-05

Natural History Study of Patients With Neurofibromatosis Type 2

National Institutes of Health Clinical Center (CC)

Recruiting
269 enrolled
CNS

Ependymoma, Meningioma, Neurilemmoma, Neuroma, Acoustic, Spinal Cord Neoplasms, Neurofibromatoses

NCT00060541 2026-06-01

Evaluation and Treatment of Neurosurgical Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
5,000 enrolled
CNSEndocrine

Brain Neoplasms, Epilepsy, Nervous System Diseases, Parkinson Disease, Pituitary Neoplasms, Spinal Cord Neoplasms

NCT02851706 2026-03-27

Natural History of and Specimen Banking for People With Tumors of the Central Nervous System

National Institutes of Health Clinical Center (CC)

Completed
1,214 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Neoplasms, Spinal Cord Neoplasms

NCT01295944 2025-08-05

Carboplatin and Bevacizumab for Recurrent Ependymoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
35 enrolled 17 charts
CNS

Brain Neoplasms, Ependymoma, Neoplasms, Neurologic Manifestations, Spinal Cord Neoplasms

NCT03173950 2025-06-29

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
133 enrolled
CNS

Brain Neoplasms, Ependymoma, Medulloblastoma, Meningioma, Pinealoma, Spinal Cord Neoplasms, Choroid Plexus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡